Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
10h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
11h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
13h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
20h agoBuffalo Potash Files Annual Information Form and New Technical Report
21h agoIonik Announces 30-Day Extension of Senior Debt Facility
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc.

About

3.14USD+0.00 +0.00%
Closed • Updated at 00:23 GMT+00:00
Market Cap$28.59M
Volume2.0K
Beta-0.66
RSI37.65
Gross Margin38.24%
Health TechnologyPharmaceuticals: Major

Lisata Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 4 2026
Kuva Intends to Commence Tender Offer for Lisata Therapeutics by May 29, 2026
Mar 6 2026
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Jan 27 2026
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Jan 21 2026
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Dec 4 2025
LSTA Releases Valuations Report on Level 3 Loans

Community Chat

Ask AI

Try asking
6ix6ixAIEvents